<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="uk">
		<id>http://istoriya.soippo.edu.ua/index.php?action=history&amp;feed=atom&amp;title=Nine_Deadly_Azastene_Errors_You_May_Be_Doing</id>
		<title>Nine Deadly Azastene Errors You May Be Doing - Історія редагувань</title>
		<link rel="self" type="application/atom+xml" href="http://istoriya.soippo.edu.ua/index.php?action=history&amp;feed=atom&amp;title=Nine_Deadly_Azastene_Errors_You_May_Be_Doing"/>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Nine_Deadly_Azastene_Errors_You_May_Be_Doing&amp;action=history"/>
		<updated>2026-04-08T10:20:17Z</updated>
		<subtitle>Історія редагувань цієї сторінки в вікі</subtitle>
		<generator>MediaWiki 1.24.1</generator>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=Nine_Deadly_Azastene_Errors_You_May_Be_Doing&amp;diff=204461&amp;oldid=prev</id>
		<title>Leek58pond: Створена сторінка: Study sponsors had no role in the design, conduct, or reporting of this research. A total of 1121 patients aged 39 to 89 years (mean age 70.0; SD 7.7; 61% men)...</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Nine_Deadly_Azastene_Errors_You_May_Be_Doing&amp;diff=204461&amp;oldid=prev"/>
				<updated>2017-07-17T14:45:18Z</updated>
		
		<summary type="html">&lt;p&gt;Створена сторінка: Study sponsors had no role in the design, conduct, or reporting of this research. A total of 1121 patients aged 39 to 89 years (mean age 70.0; SD 7.7; 61% men)...&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Нова сторінка&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Study sponsors had no role in the design, conduct, or reporting of this research. A total of 1121 patients aged 39 to 89 years (mean age 70.0; SD 7.7; 61% men) were recruited during 1998 to 2002 with a follow-up of 6 to 96 months (mean, 48 months). There was 66% of patients recruited from medical services (vascular internists, 28%; neurologists, 16%; cardiologists, 10%; hypertension clinics, 5%; metabolic units, 3%; and screening programs, 4%). Thirty-four percent of patients were recruited from surgical services (vascular, 32%; cardiac surgery, 2%). Baseline distribution of patient clinical and biochemical characteristics, degree of stenosis, and other plaque features are presented in Table I. A total of 130 first ipsilateral CORI events occurred (59 strokes of which 12 were fatal, 49 TIAs, and 22 amaurosis [http://www.selleckchem.com/products/ve-821.html VE-821 supplier] fugax). For ischemic stroke, the modified Rankin scale at 6 months was zero in 4 cases, 1 in 9 cases, 2 in 6 cases, 3 in 8 cases, 4 in 18 cases, 5 in 2 cases, and 6 in 12 cases. There were two additional first ipsilateral fatal hemorrhagic strokes. Severe and fatal ipsilateral strokes (n = 14; Rankin scores 5 and 6) occurred exclusively in plaque types 1 and 2 (10 in type 2 and 4 in type 1); also exclusively in plaques with GSM [http://www.selleckchem.com/products/GDC-0941.html Pictilisib clinical trial] (P = .006; odds ratio [OR], 3.94; 95% confidence interval [CI], 1.37-11.35). Five of these strokes occurred in the 173 patients with a history of contralateral TIA or stroke (P = .035; OR, 3.10; 95% CI, 1.03-9.38). There were 49 first contralateral [https://en.wikipedia.org/wiki/Azastene Azastene] CORI events: 18 ischemic strokes of which 7 were fatal, 22 TIAs, and 9 amaurosis fugax. There were two vertebrobasilar strokes. Of the 18 contralateral strokes, 4 occurred in the 125 patients with plaques producing 90% to 99% stenosis, 1 in the 170 producing 70% to 89% stenosis, and the remaining 13 in the 826 producing less than 70% stenosis. Plaque characterization was not performed on the contralateral side. The only factor associated with contralateral stroke was the presence of atrial fibrillation (OR, 8.28; 95% CI, 2.26-30). There was a total of 214 deaths (195 non-stroke deaths) of which 157 (73%) were due to vascular causes: MI, 110; fatal stroke, 19 (12 ipsilateral and 7 contralateral already mentioned above); heart failure, 17; pulmonary embolism, 3; lower limb ischemia/gangrene, 3; ruptured abdominal aortic aneurysm, 3; renal failure, 1; and mesenteric artery thrombosis, 1. There were 56 nonvascular deaths; malignancy, 37; pneumonia/respiratory failure, 12; gastrointestinal hemorrhage, 2; dementia, 2; road traffic accident, 2; and general surgical procedure, 1. Cause of death was unknown in 1 patient.&lt;/div&gt;</summary>
		<author><name>Leek58pond</name></author>	</entry>

	</feed>